The Interferon Papers
The good news just keeps on coming. Now, in addition to breakthrough research presented at ASH 2012 we have three of the foremost MPN specialists in the world collaborating on a comprehensive overview of the one medicine proven to produce hematological remission and reverse fibrosis in MPN!
“Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis” is the paper produced by Richard T. Silver, Jean-Jacques Kiladjian and Hans Carl Hasselbalch, just published by Expert Reviews-Hematology.
Far more than a retrospective study, this paper sets out highly specific therapeutic targets in each MPN phenotype and includes dosage recommendations so critical to avoid side effects and achieve maximum benefit. Hard to believe this won’t become the go-to document for healthcare providers, patients and caregivers.
MPNforum Magazine has scheduled “The Interferon Papers,” a detailed review of the paper and associated documents, case studies and interviews for our March issue.
- The two newest participants in the MPNclinic , Dr. Hans Carl Hasselbalch and Dr. Jean-Jacques Kiladjian have joined the senior MPNclinic member, Dr. Richard T. Silver on the panel Questions to MPNclinic can be sent to firstname.lastname@example.org